Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
---|---|---|---|
6/30/2025 | $ -38.51M | $ 5.16M | -7.46 |
3/31/2025 | $ -40.1M | $ 5.96M | -6.73 |
12/31/2024 | $ -37.76M | $ 6.75M | -5.59 |
9/30/2024 | $ -41.03M | $ 3.88M | -10.57 |
6/30/2024 | $ -21.73M | $ 2.2M | -9.89 |
3/31/2024 | $ -21.5M | $ 1.4M | -15.36 |
12/31/2023 | $ -21.06M | $ 614K | -34.29 |
9/30/2023 | $ -19.96M | $ 0 | 0 |
6/30/2023 | $ -21.68M | $ 0 | 0 |
3/31/2023 | $ -20.57M | $ 0 | 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for ERNEXA THERAPEUTICS INC is calculated as follows: EBIT [ $ -5.79M ] / Int. Exp. [ $ 249K ]
(=) Int. Coverage [ -23.26 ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.37K |
---|---|
min | -25.49 |
max | 28.75 |
average | 2.15 |
median | 2.08 |
std | 8.43 |